Autologous Transplantation of P63+Lung Progenitor Cells for Chronic Obstructive Pulmonary Disease Therapy: An Open-label, Controlled, First-in-Human Trial

被引：0
|
作者：
Zhang, T. [1 ]
Wang, Y. [2 ]
Zhou, Y. [1 ]
Zhao, Y. [2 ]
Zuo, W. [2 ]
机构：
[1] Regend Therapeut, Shanghai, Peoples R China
[2] Tongji Univ, Stem Cell Ctr, Shanghai, Peoples R China
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1221
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Autologous transplantation of P63+lung progenitor cells for chronic obstructive pulmonary disease therapy
    Wang, Yujia
    Meng, Zili
    Liu, Ming
    Zhou, Yueqing
    Chen, Difei
    Zhao, Yu
    Zhang, Ting
    Zhong, Nansha N.
    Dai, Xiaotian
    Li, Shiyue
    Zuo, Wei
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [2] Autologous transplantation of P63+ lung progenitor cells for chronic obstructive pulmonary disease therapy
    Wang, Yujia
    Meng, Zili
    Liu, Ming
    Zhou, Yueqing
    Chen, Difei
    Zhao, Yu
    Zhang, Ting
    Zhong, Nanshan
    Dai, Xiaotian
    Li, Shiyue
    Zuo, Wei
    SCIENCE TRANSLATIONAL MEDICINE, 2024, 16 (734)
  • [3] Autologous transplantation of P63+lung progenitor cells in patients with bronchiectasis: a randomized, single-blind, controlled trial
    Zuo, Wei
    Zhang, Ting
    Zhang, Weipan
    Zhao, Yu
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [4] Autologous transplantation of P63+lung progenitor cells in patients with bronchiectasis: A randomized, single-blind, controlled trial
    Yan, Jiayang
    Zhang, Weipan
    Feng, Yun
    Liu, Xuefei
    Niu, Lingyun
    Guo, Yi
    Zhou, Ling
    Shi, Mengmeng
    Di, Caixia
    Zhang, Qiurui
    Wang, Xiaofei
    Zhou, Jianping
    Dai, Ranran
    Ni, Lei
    Bao, Zhiyao
    Yan, Tianli
    Hu, Yun
    Wang, Ping
    Zhang, Ting
    Zhou, Min
    Zuo, Wei
    Qu, Jieming
    CELL REPORTS MEDICINE, 2024, 5 (11)
  • [5] Autologous transplantation of P63+lung progenitor cells (REGEND001) for idiopathic pulmonary fibrosis therapy: phase I clinical trial
    Zuo, Wei
    Zhang, Ting
    Zhang, Shiyu
    Zhao, Yu
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [6] Autologous P63+lung progenitor cell transplantation in idiopathic pulmonary fibrosis: a phase 1 clinical trial
    Zhang, Shiyu
    Zhou, Min
    Shao, Chi
    Zhao, Yu
    Liu, Mingzhe
    Ni, Lei
    Bao, Zhiyao
    Zhang, Qiurui
    Zhang, Ting
    Luo, Qun
    Qu, Jieming
    Xu, Zuojun
    Zuo, Wei
    ELIFE, 2025, 13
  • [7] Interim Analysis of Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis (HALT- IPF): A First-in-Human, Phase 1, Randomized Controlled, Open-label Trial
    Cheng, K.
    Lobo, L. J.
    Ghodsi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [8] Acupuncture treatment of lung-spleen Qi deficiency in stable chronic obstructive pulmonary disease: a randomized, open-label, controlled trial
    Li Yu
    Xiong Chan
    Zeng Yan
    Wei Hua
    Zhuang Guangtong
    Zhao Lihong
    Li Chenyi
    Li Lin
    Qin Erqi
    Chen Xiaoqin
    Fu Juanjuan
    Journal of Traditional Chinese Medicine, 2019, 39 (06) : 885 - 891
  • [9] Acupuncture treatment of lung-spleen Qi deficiency in stable chronic obstructive pulmonary disease: a randomized, open-label, controlled trial
    Li Yu
    Xiong Chan
    Zeng Yan
    Wei Hua
    Zhuang Guangtong
    Zhao Lihong
    Li Chenyi
    Li Lin
    Qin Erqi
    Chen Xiaoqin
    Fu Juanjuan
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2019, 39 (06) : 885 - 891
  • [10] Combination antibiotic therapy versus monotherapy in the treatment of acute exacerbations of chronic obstructive pulmonary disease: an open-label randomized trial
    Phuong Nguyen Thi Thu
    Minh Ngo Thị Huong
    Ngan Tran Thi
    Hoi Nguyen Thanh
    Khue Pham Minh
    BMC Infectious Diseases, 21
12345